https://www.selleckchem.com/products/ml351.html
Purpose To evaluate normalized short-wavelength fundus autofluorescence (SW-FAF) imaging changes over time as a predictive parameter for the retinal pigment epithelium (RPE) function in eyes compromised by acute central serous chorioretinopathy (CSCR) after indocyanine green angiography-guided verteporfin (Visudyne®, Novartis Pharma, Basel, Switzerland) photodynamic therapy (PDT) with a half-fluence rate (25 J/cm2). Methods Quantitative data of SW-FAF grey values (SW-FAF GV) from a 350 μm (SW-35 and 1200 μm (SW-35 and 1200 t-test was
Like
Comment
Share
